Request for Nominations on the Technical Electronic Product Radiation Safety Standards Committee, 2870 [2016-00825]

Download as PDF 2870 Federal Register / Vol. 81, No. 11 / Tuesday, January 19, 2016 / Notices FOR FURTHER INFORMATION CONTACT: DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2016–N–0001] Request for Nominations on the Technical Electronic Product Radiation Safety Standards Committee AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is requesting any industry organizations interested in participating in the selection of voting industry representatives to serve on the Technical Electronic Product Radiation Safety Standards Committee for the Center for Devices and Radiological Health to notify FDA in writing. FDA is also requesting nominations for voting industry representatives to serve on the Technical Electronic Product Radiation Safety Standards Committee. A nominee may either be self-nominated or nominated by an organization to serve as a voting industry representative. Nominations will be accepted for current vacancies effective with this notice. SUMMARY: Any industry organization interested in participating in the selection of an appropriate voting member to represent industry interests must send a letter stating that interest to FDA by February 18, 2016, (see sections I and II of this document for further details). Concurrently, nomination materials for prospective candidates should be sent to FDA by February 18, 2016. ADDRESSES: All statements of interest from industry organizations interested in participating in the selection process of voting industry representative nomination should be sent to Margaret Ames (see FOR FURTHER INFORMATION CONTACT). All nominations for voting industry representatives may be submitted electronically by accessing the FDA Advisory Committee Membership Nomination Portal: https:// www.accessdata.fda.gov/scripts/ FACTRSPortal/FACTRS/index.cfm or by mail to Advisory Committee Oversight and Management Staff, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, rm. 5103, Silver Spring, MD 20993–0002. Information about becoming a member of an FDA advisory committee can also be obtained by visiting FDA’s Web site at https:// www.fda.gov/AdvisoryCommittees/ default.htm. asabaliauskas on DSK5VPTVN1PROD with NOTICES DATES: VerDate Sep<11>2014 17:50 Jan 15, 2016 Jkt 238001 Margaret Ames, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, rm. 5234, Silver Spring, MD 20993, 301–796–5960, FAX: 301– 847–8505, margaret.ames@fda.hhs.gov. SUPPLEMENTARY INFORMATION: The Agency requests nominations for voting industry representatives to the following advisory committee: I. Technical Electronic Product Radiation Safety Standards Committee This Committee provides advice and consultation to the Commissioner of Food and Drugs on the technical feasibility, reasonableness, and practicability of performance standards for electronic products, to control the emission of radiation from such products, and may recommend electronic product radiation safety standards to the Commissioner for consideration. II. Selection Procedure Any industry organization interested in participating in the selection of an appropriate voting member to represent industry interests should send a letter stating that interest to the FDA contact (see FOR FURTHER INFORMATION CONTACT) within 30 days of publication of this document (see DATES). Within the subsequent 30 days, FDA will send a letter to each organization that has expressed an interest, attaching a complete list of all such organizations, and a list of all nominees along with their current resumes. The letter will also state that it is the responsibility of the interested organizations to confer with one another and to select a candidate, within 60 days after the receipt of the FDA letter, to serve as the voting member to represent industry interests for the committee. The interested organizations are not bound by the list of nominees in selecting a candidate. However, if no individual is selected within 60 days, the Commissioner will select the voting member to represent industry interests. III. Application Procedure Individuals may self-nominate and/or an organization may nominate one or more individuals to serve as a voting industry representative. Contact information, a current curriculum vitae, and the name of the committee of interest should be sent to the FDA Advisory Committee Membership Nomination Portal (see ADDRESSES) within 30 days of publication of this document (see DATES). FDA will forward all nominations to the organizations expressing interest in participating in PO 00000 Frm 00034 Fmt 4703 Sfmt 4703 the selection process for the committee. Persons who nominate themselves as voting industry representatives will not participate in the selection process. FDA seeks to include the views of women, men, members of all racial and ethnic groups, and individuals with and without disabilities on its advisory committees and, therefore encourages nominations of appropriately qualified candidates from these groups. This notice is issued under the Federal Advisory Committee Act (5 U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees. Dated: January 11, 2016. Jill Hartzler Warner, Associate Commissioner for Special Medical Programs. [FR Doc. 2016–00825 Filed 1–15–16; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2015–N–0001] Circulatory System Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting AGENCY: Food and Drug Administration, HHS. ACTION: Notice. This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). The meeting will be open to the public. Name of Committee: Circulatory System Devices Panel of the Medical Devices Advisory Committee. General Function of the Committee: To provide advice and recommendations to the Agency on FDA’s regulatory issues. Date and Time: The meeting will be held on March 15 and 16, 2016, from 8 a.m. to 6 p.m. Location: Holiday Inn Gaithersburg, Ballroom, Two Montgomery Village Ave., Gaithersburg, MD 20879. The hotel telephone number is 301–948– 8900. Contact Person: Dimitrus Culbreath, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, rm. 3610, Silver Spring, MD 20993– 0002, 301–796–6872, Dimitrus.Culbreath@fda.hhs.gov, or FDA Advisory Committee Information Line, 1–800–741–8138 (301–443–0572 in the Washington, DC area). A notice in the Federal Register about last minute modifications that impact a previously E:\FR\FM\19JAN1.SGM 19JAN1

Agencies

[Federal Register Volume 81, Number 11 (Tuesday, January 19, 2016)]
[Notices]
[Page 2870]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-00825]



[[Page 2870]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2016-N-0001]


Request for Nominations on the Technical Electronic Product 
Radiation Safety Standards Committee

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is requesting any 
industry organizations interested in participating in the selection of 
voting industry representatives to serve on the Technical Electronic 
Product Radiation Safety Standards Committee for the Center for Devices 
and Radiological Health to notify FDA in writing. FDA is also 
requesting nominations for voting industry representatives to serve on 
the Technical Electronic Product Radiation Safety Standards Committee. 
A nominee may either be self-nominated or nominated by an organization 
to serve as a voting industry representative. Nominations will be 
accepted for current vacancies effective with this notice.

DATES: Any industry organization interested in participating in the 
selection of an appropriate voting member to represent industry 
interests must send a letter stating that interest to FDA by February 
18, 2016, (see sections I and II of this document for further details). 
Concurrently, nomination materials for prospective candidates should be 
sent to FDA by February 18, 2016.

ADDRESSES: All statements of interest from industry organizations 
interested in participating in the selection process of voting industry 
representative nomination should be sent to Margaret Ames (see FOR 
FURTHER INFORMATION CONTACT). All nominations for voting industry 
representatives may be submitted electronically by accessing the FDA 
Advisory Committee Membership Nomination Portal: https://www.accessdata.fda.gov/scripts/FACTRSPortal/FACTRS/index.cfm or by mail 
to Advisory Committee Oversight and Management Staff, Food and Drug 
Administration, 10903 New Hampshire Ave., Bldg. 32, rm. 5103, Silver 
Spring, MD 20993-0002. Information about becoming a member of an FDA 
advisory committee can also be obtained by visiting FDA's Web site at 
https://www.fda.gov/AdvisoryCommittees/default.htm.

FOR FURTHER INFORMATION CONTACT: Margaret Ames, Center for Devices and 
Radiological Health, Food and Drug Administration, 10903 New Hampshire 
Ave., Bldg. 66, rm. 5234, Silver Spring, MD 20993, 301-796-5960, FAX: 
301-847-8505, margaret.ames@fda.hhs.gov.

SUPPLEMENTARY INFORMATION: The Agency requests nominations for voting 
industry representatives to the following advisory committee:

I. Technical Electronic Product Radiation Safety Standards Committee

    This Committee provides advice and consultation to the Commissioner 
of Food and Drugs on the technical feasibility, reasonableness, and 
practicability of performance standards for electronic products, to 
control the emission of radiation from such products, and may recommend 
electronic product radiation safety standards to the Commissioner for 
consideration.

II. Selection Procedure

    Any industry organization interested in participating in the 
selection of an appropriate voting member to represent industry 
interests should send a letter stating that interest to the FDA contact 
(see FOR FURTHER INFORMATION CONTACT) within 30 days of publication of 
this document (see DATES). Within the subsequent 30 days, FDA will send 
a letter to each organization that has expressed an interest, attaching 
a complete list of all such organizations, and a list of all nominees 
along with their current resumes. The letter will also state that it is 
the responsibility of the interested organizations to confer with one 
another and to select a candidate, within 60 days after the receipt of 
the FDA letter, to serve as the voting member to represent industry 
interests for the committee. The interested organizations are not bound 
by the list of nominees in selecting a candidate. However, if no 
individual is selected within 60 days, the Commissioner will select the 
voting member to represent industry interests.

III. Application Procedure

    Individuals may self-nominate and/or an organization may nominate 
one or more individuals to serve as a voting industry representative. 
Contact information, a current curriculum vitae, and the name of the 
committee of interest should be sent to the FDA Advisory Committee 
Membership Nomination Portal (see ADDRESSES) within 30 days of 
publication of this document (see DATES). FDA will forward all 
nominations to the organizations expressing interest in participating 
in the selection process for the committee. Persons who nominate 
themselves as voting industry representatives will not participate in 
the selection process.
    FDA seeks to include the views of women, men, members of all racial 
and ethnic groups, and individuals with and without disabilities on its 
advisory committees and, therefore encourages nominations of 
appropriately qualified candidates from these groups.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees.

    Dated: January 11, 2016.
Jill Hartzler Warner,
Associate Commissioner for Special Medical Programs.
[FR Doc. 2016-00825 Filed 1-15-16; 8:45 am]
 BILLING CODE 4164-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.